ArticleBiomedicines2022

Development and Biological Characterization of a Novel Selective TrkA Agonist with Neuroprotective Properties against Amyloid Toxicity.

Thanasis Rogdakis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.